Free tool
Healthcare stocks
We cover 110 companies in the Healthcare sector. The median market value in the group is $838.85M. Across the group, the median move over the past trading day is 0.00%. 52% of the 106 with a 200-day average trade above it. Price change over the past year runs from −55.3% to +61.6% across the middle 80 percent of the group, with a median of −7.1%.
Other lists in this group
Table
110 of 2,203 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return | Next report |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | $270.00 | +1.23% | +31.66% | +55.40% | Oct 13, 2026 |
| JNJ.DE | Johnson & Johnson | 234.20 EUR | −0.62% | +34.82% | +58.93% | Oct 13, 2026 |
| TMO | Thermo Fisher Scientific Inc. | $633.71 | +9.94% | +7.06% | +30.17% | Oct 21, 2026 |
| TN8.DE | Thermo Fisher Scientific Inc. | 537.00 EUR | +5.63% | +6.86% | +29.67% | Oct 21, 2026 |
| ABL.DE | Abbott Laboratories | 98.74 EUR | +2.64% | −5.19% | −10.02% | Oct 14, 2026 |
| HQY | HealthEquity, Inc. | $104.42 | +3.14% | +14.66% | +18.69% | Aug 27, 2026 |
| RHC.AX | Ramsay Health Care Limited | 50.09 AUD | +13.17% | +46.21% | +50.11% | Aug 27, 2026 |
| GETI-B.ST | Getinge AB (publ) | 243.30 SEK | +2.18% | +14.56% | +20.89% | Oct 21, 2026 |
| 3391.T | Tsuruha Holdings Inc. | 2,379.00 JPY | −8.08% | −16.55% | +5.97% | Oct 9, 2026 |
| 0126Z0.KS | SAMSUNG EPIS HOLDINGS | 387,000.00 KRW | +9.79% | −45.87% | +15.35% | Oct 23, 2026 |
| SECT-B.ST | Sectra AB (publ) | 276.20 SEK | −2.47% | +15.28% | −17.02% | Sep 4, 2026 |
| MMED | MiniMed Group, Inc. | $19.49 | +10.49% | +5.41% | +5.41% | Sep 1, 2026 |
| BBZA.DE | BB Biotech AG | 33.40 EUR | 0.00% | +7.22% | +7.22% | Oct 23, 2026 |
| FIE.DE | Fielmann Group AG | 39.25 EUR | −5.08% | −10.08% | −27.31% | Aug 27, 2026 |
| 3349.T | COSMOS Pharmaceutical Corporation | 6,559.00 JPY | −6.35% | −14.64% | −26.59% | Oct 13, 2026 |
| VIRP.PA | Virbac SA | 329.00 EUR | −5.32% | −6.93% | −2.08% | Sep 17, 2026 |
| 7649.T | Sugi Holdings Co.,Ltd. | 2,682.50 JPY | −11.53% | −26.40% | −28.60% | Oct 8, 2026 |
| NRIX | Nurix Therapeutics, Inc. | $26.71 | +10.60% | +47.90% | +179.69% | Oct 8, 2026 |
| EMEIS.PA | emeis Société anonyme | 13.80 EUR | −0.86% | −5.61% | +10.93% | Sep 23, 2026 |
| NEOG | Neogen Corporation | $11.70 | +27.31% | +67.14% | +103.83% | Oct 8, 2026 |
| 3549.T | Kusuri No Aoki Holdings Co., Ltd. | 4,115.00 JPY | −2.00% | −8.02% | +5.23% | Oct 1, 2026 |
| NBTX | Nanobiotix S.A. | $44.50 | +17.66% | +101.08% | +394.99% | Sep 29, 2026 |
| MSB.AX | Mesoblast Limited | 2.45 AUD | +19.85% | −11.73% | +1.03% | Aug 27, 2026 |
| MESO | Mesoblast Limited | $16.84 | +16.54% | −7.27% | +4.47% | Aug 27, 2026 |
| EKTA-B.ST | Elekta AB (publ) | 56.05 SEK | +14.95% | +0.87% | +26.10% | Aug 27, 2026 |
| 302440.KS | SK bioscience Co.,Ltd. | 38,100.00 KRW | +17.23% | −20.62% | −20.29% | Oct 26, 2026 |
| ALIF-B.ST | AddLife AB (publ) | 162.30 SEK | +0.87% | +8.17% | −7.20% | Oct 21, 2026 |
| GNS.L | Genus plc | 2,298.00 GBP | +3.23% | −9.70% | −12.94% | Sep 10, 2026 |
| NANO.PA | Nanobiotix S.A. | 35.74 EUR | +8.43% | +88.11% | +358.21% | Sep 29, 2026 |
| VIMIAN.ST | Vimian Group AB (publ) | 35.35 SEK | +1.58% | +15.22% | +12.01% | Oct 22, 2026 |
| EMBLA.CO | Embla Medical hf. | 30.15 DKK | +5.05% | −5.78% | −6.94% | Oct 20, 2026 |
| HCSG | Healthcare Services Group, Inc. | $22.91 | −3.54% | +32.05% | +47.05% | Oct 21, 2026 |
| BONEX.ST | Bonesupport Holding AB (publ) | 224.40 SEK | +1.54% | +26.07% | −28.26% | Oct 22, 2026 |
| KMTS | Kestra Medical Technologies, Ltd. | $26.57 | +11.36% | +8.94% | +47.61% | Sep 14, 2026 |
| DIA.WA | Diagnostyka S.A. | 167.60 PLN | +0.72% | −3.07% | −17.76% | Sep 10, 2026 |
| INNV | InnovAge Holding Corp. | $11.04 | −6.52% | +112.72% | +178.79% | Sep 8, 2026 |
| GDS.PA | Ramsay Générale de Santé SA | 10.95 EUR | −0.45% | +17.24% | +9.50% | Oct 16, 2026 |
| 9627.T | Ain Holdings Inc. | 6,142.00 JPY | −2.57% | −5.73% | +2.85% | Sep 14, 2026 |
| VITR.ST | Vitrolife AB (publ) | 95.10 SEK | +9.31% | −27.76% | −30.23% | Oct 22, 2026 |
| CHEMM.CO | ChemoMetec A/S | 496.80 DKK | +15.59% | −26.35% | −3.94% | Sep 10, 2026 |
| SPI.L | Spire Healthcare Group plc | 237.00 GBP | +1.28% | +40.25% | +7.25% | Sep 9, 2026 |
| BIOG-B.ST | BioGaia AB (publ) | 117.10 SEK | +1.39% | +15.05% | +13.96% | Oct 22, 2026 |
| SNZ.AX | Summerset Group Holdings Limited | 7.00 AUD | −0.14% | −32.73% | −26.63% | Aug 27, 2026 |
| CVSG.L | CVS Group plc | 1,296.00 GBP | +3.27% | +1.73% | +2.05% | Sep 24, 2026 |
| IVA.PA | Inventiva S.A. | 4.09 EUR | +3.94% | +0.99% | −14.63% | Sep 25, 2026 |
| IVA | Inventiva S.A. | $4.82 | +3.88% | +1.26% | −7.84% | Sep 25, 2026 |
| TTALO.HE | Terveystalo Oyj | 7.78 EUR | +4.29% | −16.20% | −22.31% | Oct 21, 2026 |
| GXI.DE | Gerresheimer AG | 25.58 EUR | −9.23% | −7.99% | −39.73% | Aug 27, 2026 |
| 7730.T | Mani, Inc. | 1,607.00 JPY | +5.38% | +10.38% | +29.48% | Oct 15, 2026 |
| VETO.PA | Vetoquinol SA | 70.60 EUR | −3.29% | −16.35% | −6.37% | Sep 11, 2026 |
| XVIVO.ST | Xvivo Perfusion AB (publ) | 278.80 SEK | +9.08% | +53.95% | +59.31% | Oct 22, 2026 |
| 3046.T | JINS HOLDINGS Inc. | 6,230.00 JPY | −9.58% | +14.30% | −22.48% | Oct 9, 2026 |
| MCAP.ST | MedCap AB (publ) | 554.50 SEK | +3.64% | +4.03% | −10.28% | Oct 23, 2026 |
| DYVOX.ST | Dynavox Group AB (publ) | 76.70 SEK | +4.14% | −21.71% | −39.29% | Oct 21, 2026 |
| OXB.L | Oxford Biomedica plc | 515.00 GBP | −5.68% | −21.37% | −9.81% | Sep 23, 2026 |
| GNFT.PA | Genfit S.A. | 14.30 EUR | +5.30% | +172.38% | +310.45% | Sep 29, 2026 |
| ARJO-B.ST | Arjo AB (publ) | 28.38 SEK | +4.11% | −6.88% | −15.25% | Oct 22, 2026 |
| PHR | Phreesia, Inc. | $11.60 | +6.81% | −28.83% | −63.74% | Sep 2, 2026 |
| ANGO | AngioDynamics, Inc. | $15.69 | +9.41% | +23.74% | +56.74% | Oct 1, 2026 |
| TLRY.TO | Tilray Brands, Inc. | 6.46 CAD | +13.73% | −51.61% | +240.00% | Oct 8, 2026 |
| TLRY | Tilray Brands, Inc. | $4.64 | +15.14% | −52.26% | −66.13% | Oct 8, 2026 |
| EQS.PA | Equasens Société anonyme | 34.05 EUR | −1.02% | −24.08% | −25.98% | Sep 28, 2026 |
| MEDI.OL | Medistim ASA | 263.00 NOK | +16.37% | +4.43% | +4.43% | Oct 23, 2026 |
| 4592.T | SanBio Company Limited | 997.00 JPY | +10.78% | −39.10% | −57.08% | Sep 14, 2026 |
| REG1V.HE | Revenio Group Oyj | 14.78 EUR | +16.56% | −33.12% | −38.54% | Sep 8, 2026 |
| NRC | NRC Health | $22.00 | −1.52% | +23.14% | +45.92% | Oct 26, 2026 |
| RZLT | Rezolute, Inc. | $5.04 | +2.44% | +132.79% | −30.00% | Sep 16, 2026 |
| BNTC | Benitec Biopharma Inc. | $12.88 | +8.33% | +2.34% | +0.16% | Sep 22, 2026 |
| PRTC.L | PureTech Health plc | 121.20 GBP | +0.17% | −2.73% | −4.27% | Aug 27, 2026 |
| NIOX.L | NIOX Group Plc | 66.60 GBP | +8.82% | −2.03% | −9.49% | Sep 29, 2026 |
| CRNA.OL | Circio Holding ASA | 11.92 NOK | +37.80% | +877.05% | +1733.85% | Aug 31, 2026 |
| HUM.ST | Humana AB (publ) | 71.70 SEK | +14.72% | +46.12% | +81.84% | Oct 22, 2026 |
| CUV.AX | Clinuvel Pharmaceuticals Limited | 9.36 AUD | −2.40% | −26.36% | −24.94% | Aug 27, 2026 |
| TRMED.OL | Thor Medical ASA | 6.76 NOK | +51.91% | +34.93% | +135.13% | Aug 28, 2026 |
| XUP.DE | Genfit S.A. | 14.08 EUR | −1.81% | +164.41% | +166.82% | Sep 29, 2026 |
| IPHA | Innate Pharma S.A. | $2.16 | +28.57% | +18.68% | +2.86% | Sep 17, 2026 |
| IDD.DE | Innate Pharma S.A. | 1.78 EUR | +12.80% | +12.80% | −2.52% | Sep 17, 2026 |
| SY | So-Young International Inc. | $2.40 | +22.45% | −10.11% | −38.93% | Aug 31, 2026 |
| IPH.PA | Innate Pharma S.A. | 1.88 EUR | +19.01% | +16.21% | +1.19% | Sep 17, 2026 |
| UTMD | Utah Medical Products, Inc. | $70.89 | −0.10% | +26.08% | +17.76% | Oct 22, 2026 |
| HITI | High Tide Inc. | $2.52 | +22.33% | −10.00% | −30.00% | Sep 14, 2026 |
| PDEX | Pro-Dex, Inc. | $63.84 | +13.31% | +69.25% | +40.31% | Aug 27, 2026 |
| ALCGM.PA | Cegedim SA | 10.26 EUR | +1.38% | −25.92% | −4.56% | Sep 24, 2026 |
| BINV.ST | BioInvent International AB (publ) | 24.30 SEK | +5.42% | −17.21% | −23.46% | Aug 27, 2026 |
| SEDANA.ST | Sedana Medical AB (publ) | 12.02 SEK | +23.92% | +12.13% | −22.05% | Oct 22, 2026 |
| ENGN | enGene Therapeutics Inc. | $1.95 | +10.80% | −77.97% | −55.07% | Sep 14, 2026 |
| ANIX | Anixa Biosciences, Inc. | $3.61 | +2.41% | +14.08% | +22.20% | Sep 9, 2026 |
| OSE.PA | OSE Immunotherapeutics SA | 3.21 EUR | −0.19% | −39.40% | −47.94% | Sep 28, 2026 |
| NNOX | Nano-X Imaging Ltd. | $0.88 | −0.25% | −69.05% | −77.77% | Sep 9, 2026 |
| CSBR | Champions Oncology, Inc. | $4.92 | −11.03% | −26.13% | −25.45% | Sep 14, 2026 |
| ONCO.ST | Oncopeptides AB (publ) | 1.65 SEK | +2.93% | −66.11% | −67.92% | Aug 27, 2026 |
| HYFT | MindWalk Holdings Corp. | $1.43 | +5.15% | −29.21% | −46.04% | Sep 14, 2026 |
| LYTIX.OL | Lytix Biopharma ASA | 7.78 NOK | −11.59% | −22.04% | −4.19% | Aug 27, 2026 |
| IMMP | Immutep Limited | $0.38 | −2.56% | −87.12% | −77.11% | Sep 2, 2026 |
| BACTI-B.ST | Bactiguard Holding AB (publ) | 14.35 SEK | −8.89% | −24.47% | −46.25% | Oct 22, 2026 |
| AIFORIA.HE | Aiforia Technologies Oyj | 1.17 EUR | +2.99% | −52.44% | −60.34% | Aug 28, 2026 |
| ORX.ST | Orexo AB (publ) | 13.54 SEK | −5.71% | −58.27% | −35.06% | Oct 22, 2026 |
| POCI | Precision Optics Corporation, Inc. | $4.35 | −2.03% | +2.35% | −12.30% | Sep 28, 2026 |
| ONCIN.OL | Oncoinvent ASA | 85.00 NOK | −2.07% | +80.85% | +10.90% | Aug 27, 2026 |
| LITS | Lite Strategy, Inc. | $0.99 | +2.38% | −35.51% | −80.75% | Sep 28, 2026 |
| PSH0.DE | Sernova Biotherapeutics Inc | 0.08 EUR | +14.41% | −2.99% | −27.68% | Sep 10, 2026 |
| SVA.TO | Sernova Biotherapeutics Inc | 0.11 CAD | −8.33% | −15.38% | −42.11% | Sep 10, 2026 |
| CONTX.OL | ContextVision AB (publ) | 3.55 NOK | +3.20% | −14.46% | −21.11% | Aug 27, 2026 |
| INTEG-B.ST | Integrum AB (publ) | 8.66 SEK | −0.92% | −16.73% | −79.55% | Sep 3, 2026 |
| AELIS.PA | Aelis Farma SA | 1.03 EUR | +0.39% | −11.21% | −19.22% | Sep 15, 2026 |
| BLRX | BioLineRx Ltd. | $2.70 | −3.91% | −3.57% | −26.63% | Aug 31, 2026 |
| LNAI | Lunai Bioworks Inc. | $2.20 | −1.79% | −71.71% | −89.34% | Sep 28, 2026 |
| INM | InMed Pharmaceuticals Inc. | $1.43 | −14.37% | +27.68% | −36.44% | Sep 23, 2026 |
| AVNT.TO | Avant Brands Inc. | 0.60 CAD | +3.45% | −34.07% | −28.57% | Oct 15, 2026 |
| CLGN | CollPlant Biotechnologies Ltd. | $0.31 | −6.25% | −79.22% | −89.43% | Aug 27, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.